A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

NCT06503731 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Antibody-mediated Rejection

Interventions

COMBINATION_PRODUCT: Efgartigimod PH20 SC - prefilled syringe
OTHER: Placebo PH20 SC - prefilled syringe

Sponsor

argenx